| SYS | | 0084896 |
|---|
| LBL | | 00000naa^^22^^^^^^^^450 |
|---|
| 005 | | 20170103092241.9 |
|---|
| 100 | | $a 20130213a2012 m y0sloy0103 ba |
|---|
| 101 | 0- | $a slo |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Nové spôsoby liečby celiakie |
|---|
| 215 | | $c ilustr. (fareb.), obr., sch., tab. |
|---|
| 305 | | $a S. Rashtak, J. A. Murray: Alimentary Pharmacology & Therapeutics 2012, 35, 7: 768-781 |
|---|
| 463 | -1 | $1 001 sllk_un_cat*0082277 $1 200 1 $a Lekárske listy $e odborná príloha Zdravotníckych novín $i Interné lekárstvo $v Č. 39 (2012), s. 8-13 $1 210 $a Bratislava $c Ecopress $d 2012 $1 215 $a s. 2-23 |
|---|
| 606 | 1- | $3 sllk_un_auth*d002446 $a celiakia $x dietoterapia $x terapia $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d055050 $a diéta bezlepková $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d000529 $a terapie komplementárne $x metódy $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d005983 $a glutény $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d014908 $a Triticum $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d030821 $a rastliny geneticky modifikované $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d011503 $a transglutaminázy $x antagonisty a inhibítory $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d006683 $a antigény HLA-DQ $x imunológia $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d000893 $a antiflogistiká $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d007371 $a interferón gama $x antagonisty a inhibítory $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d014409 $a faktor nekrotizujúci nádory, alfa $x antagonisty a inhibítory $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d019409 $a interleukín-15 $x antagonisty a inhibítory $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d016753 $a interleukín-10 $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d014611 $a vakcinácia $2 mesh |
|---|
| 710 | 02 | $3 sllk_un_auth*0023828 $a Redakcia Lekárske listy $4 010 |
|---|
| 801 | -0 | $a SK $b BA006 $c 20130213 $g AACR2 |
|---|
